Inspire Medical Systems, Inc. (INSP) Stock Price & Analysis

Inspire Medical Systems, Inc. (INSP) fell 1.31% to USD 62.26 as of September 8, 2026 at 17:31 UTC, according to Nexqual real-time market data.

INSP last closed at USD 62.26; the session ranged USD 61.69–63.74 on volume of 215,713 shares. Market capitalization is —, with a 52-week range of USD 38.91–147.03 (NYQ). Source: Nexqual, September 8, 2026 at 17:31 UTC.

Key Statistics (as of September 8, 2026 at 17:31 UTC)

Technical Analysis (INSP)

Nexqual's technical model rates INSP "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 8, 2026 at 17:31 UTC.

From Inspire Medical Systems, Inc.'s Latest SEC 10-K Filing (filed 2026-02-13)

Key Strengths & Strategy (as disclosed to the SEC)

• Our proprietary Inspire system is the first FDA, European Union ("EU") Regulation No. 2017/745 ("MDR" or "EU Medical Devices Regulation"), and Japan Pharmaceuticals and Medical Devices Agency-approved neurostimulation technology of its kind that provides a safe and effective treatment for patients with moderate to severe OSA.
• Our Solution for OSA Overview of Inspire Therapy Our proprietary Inspire system is the first FDA-approved closed-loop neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.
• Our proprietary algorithm tracks breathing patterns and the neurostimulator delivers electrical stimulation at the start of inspiration.
• We have developed the first FDA-approved neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA who have been confirmed to fail or cannot tolerate PAP treatments, such as CPAP.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:31 UTC. This page is informational and not investment advice.